郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

病毒感染Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model.

期刊：mBio发表年份：2021作者：Shiho Chiba; Maki Kiso; Noriko Nakajima; Shun Iida; Tadashi Maemura; Makoto Kuroda; Yuko Sato; Mutsumi Ito; Moe Okuda; Shinya Yamada; Kiyoko Iwatsuki-Horimoto; Tokiko Watanabe; Masaki Imai; Tammy Armbrust; Ralph S Baric; Peter J Halfmann; Tadaki Suzu
阅读更多 →

病毒感染Prevalence of the novel recombinant LSDV in east and Southeast Asia: Inducing skin and testicular damage in golden hamsters.

期刊：Microbial pathogenesis发表年份：2024作者：Jingyu Wang; Shaobing Wan; Shizhe Liu; Zhen Wang; Xiaoqing Ding; Qianwen Wu; Xin Liu; Zihan Chen; Ling Chen; Heng Wang; Kun Jia; Shoujun Li
阅读更多 →

病毒感染Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamsters.

期刊：Frontiers in immunology发表年份：2023作者：Hannah A D King; Vincent Dussupt; Letzibeth Mendez-Rivera; Bonnie M Slike; Ursula Tran; Nathan D Jackson; Erica Barkei; Michelle Zemil; Emily Tourtellott-Fogt; Caitlin H Kuklis; Sandrine Soman; Aslaa Ahmed; Maciel Porto; Christopher Kitajewski; Britt
阅读更多 →

病毒感染Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model.

期刊：The Journal of infectious diseases发表年份：2021作者：Rana Abdelnabi; Caroline S Foo; Steven De Jonghe; Piet Maes; Birgit Weynand; Johan Neyts
阅读更多 →